ID: ALA3908323

Max Phase: Preclinical

Molecular Formula: C25H15ClN6O3

Molecular Weight: 482.89

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N#Cc1c(NC(=O)c2ccc(Cl)c([N+](=O)[O-])c2)n(Cc2ccccc2)c2nc3ccccc3nc12

Standard InChI:  InChI=1S/C25H15ClN6O3/c26-18-11-10-16(12-21(18)32(34)35)25(33)30-23-17(13-27)22-24(29-20-9-5-4-8-19(20)28-22)31(23)14-15-6-2-1-3-7-15/h1-12H,14H2,(H,30,33)

Standard InChI Key:  OFJFAJHQAVKRSQ-UHFFFAOYSA-N

Associated Targets(non-human)

lpdC Dihydrolipoyl dehydrogenase (124 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
dlaT Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex (54 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 482.89Molecular Weight (Monoisotopic): 482.0894AlogP: 5.32#Rotatable Bonds: 5
Polar Surface Area: 126.74Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.27CX Basic pKa: CX LogP: 5.68CX LogD: 5.68
Aromatic Rings: 5Heavy Atoms: 35QED Weighted: 0.27Np Likeness Score: -1.83

References

1.  (2015)  Compounds and methods for treating tuberculosis infection, 

Source

Source(1):